Kezar Life Sciences, Inc.KZRNASDAQ
LOADING
|||
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 19.75% |
| Q2 2025 | 17.19% |
| Q1 2025 | 18.24% |
| Q4 2024 | 1.75% |
| Q3 2024 | 6.14% |
| Q2 2024 | 1.38% |
| Q1 2024 | 16.52% |
| Q4 2023 | -11.26% |
| Q3 2023 | 4.69% |
| Q2 2023 | -9.22% |
| Q1 2023 | -22.41% |
| Q4 2022 | -5.85% |
| Q3 2022 | -15.95% |
| Q2 2022 | -2.80% |
| Q1 2022 | -12.59% |
| Q4 2021 | 2.73% |
| Q3 2021 | -11.45% |
| Q2 2021 | 0.30% |
| Q1 2021 | -17.89% |
| Q4 2020 | 4.18% |
| Q3 2020 | -17.23% |
| Q2 2020 | 5.96% |
| Q1 2020 | -4.81% |
| Q4 2019 | -3.26% |
| Q3 2019 | -3.48% |
| Q2 2019 | -12.59% |
| Q1 2019 | -29.30% |
| Q4 2018 | -2.59% |
| Q3 2018 | 9.87% |
| Q2 2018 | -36.65% |
| Q1 2018 | -110.25% |
| Q4 2017 | -10.36% |
| Q3 2017 | -16.53% |
| Q2 2017 | 16.66% |
| Q1 2017 | 0.00% |